Cambium Networks Appoints Mitchell Cohen as Interim CFO Amid Nasdaq Compliance Update

Cambium Networks Corporation (CMBM) announced a significant leadership transition and a mixed regulatory update on Thursday. The networking solutions provider appointed Mitchell Cohen to serve as interim chief financial officer and principal financial officer, effective immediately. Cohen’s appointment comes with strong credentials spanning public companies, private equity operations, and high-growth ventures. Since 2022, Cohen has held interim CFO positions at multiple organizations, bringing relevant experience to the role.

CFO Transition and Leadership Changes

John Waldron, who had been managing the CFO responsibilities on an acting basis, will transition to a senior financial advisor position within the company. This move marks a formal restructuring of the finance leadership function with Cohen name entering the operational framework to provide interim guidance during this period.

Nasdaq Compliance: Progress and Remaining Challenges

Cambium received a partial compliance determination from the Nasdaq Hearings Panel on December 12. The company has successfully achieved compliance with the Minimum Bid Price Rule, demonstrating improvement in this specific area. However, the company continues to face non-compliance issues related to the Periodic Filing Rule, which remains an outstanding concern.

The Nasdaq panel will maintain jurisdiction over the company through April 8, 2026. Additionally, Cambium will be subject to mandatory monitoring requirements extending through December 12, 2026. During this extended monitoring window, any failure to maintain the minimum bid price threshold could trigger delisting proceedings.

Market Response

Following the announcement, Cambium Networks shares gained traction in pre-market trading, rising more than 5% from Wednesday’s closing price of $1.55, which had declined 4.32% the previous session. The positive pre-market movement suggests investor optimism regarding the leadership appointment and compliance progress.

The company’s regulatory timeline now hinges on sustained compliance efforts over the coming months, with the path forward dependent on meeting filing requirements and maintaining stock price standards through the monitoring period.